Section Arrow
Quote
SNOA.NASDAQ
- Sonoma Pharmaceuticals Inc
Quotes are at least 15-min delayed:2025/02/23 10:48 EST
Last
 2.395
-0.025 (-1.03%)
Day High 
2.47 
Prev. Close
2.42 
1-M High
3.04 
Volume 
39.28K 
Bid
2.26
Ask
2.47
Day Low
2.32 
Open
2.42 
1-M Low
2.3 
Market Cap 
3.91M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 2.55 
20-SMA 2.62 
50-SMA 2.66 
52-W High 9.374 
52-W Low 2.3 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.26/-3.82
Enterprise Value
4.00M
Balance Sheet
Book Value Per Share
3.01
Cash Flow
Cash Flow Yield
0.06
Income Statement
Total Revenue
12.74M
Operating Revenue Per Share
7.87
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
UPCUniverse Pharmaceuticals Inc0.2003+0.0578+40.56%-- 
TLRYTilray Brands0.9452+0.0775+8.93%-- 
CGCCanopy Growth Corp1.615+0.005+0.31%-- 
TXMDTherapeuticsMD1.291+0.281+27.82%0.39PE
TEVATeva Pharmaceutical Industries Limited16.74-0.26-1.53%-- 
Quotes are at least 15-min delayed：2025/02/23 10:48 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.